ResearcherUniversidade do PortoNo recent work listed
Pedro Moutinho-Ribeiro
Matched on ORCID iD 0000-0002-4782-6489; OpenAlex author ID A5039433956. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 3 papers
Papers 8
- Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis. Co-author DOI 10.1016/j.dld.2021.10.012↗
- Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression. Co-author DOI 10.1136/gutjnl-2021-324994↗
- Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities. Co-author DOI 10.3748/wjg.v28.i31.4310↗
- GRUPUGE Perspective: Endoscopic Ultrasound-Guided Fine-Needle Tattooing and Fiducial Placement in Pancreatic Cancer. Last author DOI 10.1159/000509194↗
- Endoscopic ultrasound in pancreatic cancer treatment: Facts and hopes. Co-author DOI 10.1016/j.clinre.2019.02.014↗
- Early pancreatic cancer - The role of endoscopic ultrasound with or without tissue acquisition in diagnosis and staging. Co-author DOI 10.1016/j.dld.2018.09.027↗
- Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble? Co-author DOI 10.3389/fendo.2018.00779↗
- Pancreatic cancer screening: Still a delusion? Co-author DOI 10.1016/j.pan.2017.07.001↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Guilherme Macedo · 7 shared papers, 2017–2022 · strength 0.88
- Paper Endoscopic ultrasound in pancreatic cancer treatment: Facts and hopes. DOI 10.1016/j.clinre.2019.02.014↗
- Paper Early pancreatic cancer - The role of endoscopic ultrasound with or without tissue acquisition in diagnosis and staging. DOI 10.1016/j.dld.2018.09.027↗
- Paper Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble? DOI 10.3389/fendo.2018.00779↗
- Sónia A. Melo · 4 shared papers, 2018–2022 · strength 0.49
- Paper Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble? DOI 10.3389/fendo.2018.00779↗
- Paper Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis. DOI 10.1016/j.dld.2021.10.012↗
- Paper Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of… DOI 10.3748/wjg.v28.i31.4310↗
- Inês A. Batista · 3 shared papers, 2022 · strength 0.35
- Paper Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis. DOI 10.1016/j.dld.2021.10.012↗
- Paper Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of… DOI 10.3748/wjg.v28.i31.4310↗
- Paper Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumou… DOI 10.1136/gutjnl-2021-324994↗
- Bárbara Adem · 3 shared papers, 2022 · strength 0.35
- Paper Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis. DOI 10.1016/j.dld.2021.10.012↗
- Paper Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of… DOI 10.3748/wjg.v28.i31.4310↗
- Paper Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumou… DOI 10.1136/gutjnl-2021-324994↗
- Carolina F. Ruivo · 2 shared papers, 2022 · strength 0.23
- Susana Marques · 1 shared paper, 2021 · strength 0.15
- Miguel Bispo · 1 shared paper, 2021 · strength 0.15
- Julio Iglesias‐García · 1 shared paper, 2019 · strength 0.14
- Nuno Bastos · 1 shared paper, 2022 · strength 0.11
- Raghu Kalluri · 1 shared paper, 2022 · strength 0.11
- Marilia L. Cravo · 1 shared paper, 2022 · strength 0.11
- Marc F. Giovannini · 1 shared paper, 2017 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.